Chenji Wang
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- Molecular Biology top 5%
- Ubiquitin and proteasome pathways
- RNA modifications and cancer
- Epigenetics and DNA Methylation
Papers in
-
- Ubiquitin and proteasome pathways 26
- RNA modifications and cancer 10
- RNA Research and Splicing 6
-
- Cancer-related molecular mechanisms research 7
- Co-authors
- Long Yu (24 shared papers)Pingzhao Zhang (27 shared papers)Haojie Huang (10 shared papers)Kun Gao (28 shared papers)Jian An (4 shared papers)Yibin Deng (1 shared paper)Jiucun Wang (5 shared papers)Yinghui Zhou (5 shared papers)
- Journals
- Cell Death and Differentiation (5 papers)Cell Death and Disease (4 papers)Cancer Letters (4 papers)PLoS ONE (3 papers)Autophagy (3 papers)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Chenji Wang
79 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 116
- Cancer Research 514
- Molecular Biology 1.4k
- Cell Biology 270
- Oncology 343
- Pulmonary and Respiratory Medicine 371
Countries citing papers authored by Chenji Wang
This map shows the geographic impact of Chenji Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chenji Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chenji Wang more than expected).
Fields of papers citing papers by Chenji Wang
This network shows the impact of papers produced by Chenji Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chenji Wang. The network helps show where Chenji Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Chenji Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 86 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 319 | |
| 2 | 2014 | 196 | |
| 3 | 2010 | 99 | |
| 4 | 2021 | 82 | |
| 5 | 2023 | 75 | |
| 6 | 2015 | 64 | |
| 7 | 2012 | 63 | |
| 8 | 2012 | 61 | |
| 9 | 2017 | 61 | |
| 10 | 2017 | 55 | |
| 11 | TRIM21 overexpression promotes tumor progression by regulating cell proliferation, cell migration and cell senescence in human glioma. | 2020 | 50 |
| 12 | 2018 | 48 | |
| 13 | 2011 | 47 | |
| 14 | 2011 | 44 | |
| 15 | 2020 | 41 | |
| 16 | ARRDC1 and ARRDC3 act as tumor suppressors in renal cell carcinoma by facilitating YAP1 degradation. | 2018 | 38 |
| 17 | 2015 | 36 | |
| 18 | Tumor suppressor SPOP mediates the proteasomal degradation of progesterone receptors (PRs) in breast cancer cells. | 2015 | 36 |
| 19 | 2015 | 34 | |
| 20 | 2012 | 34 |
About Chenji Wang
Chenji Wang is a scholar working on Molecular Biology, Cancer Research, Cell Biology, Oncology and Pulmonary and Respiratory Medicine, having authored 86 papers that have together received 2.2k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (26 papers), RNA modifications and cancer (10 papers), Cancer-related Molecular Pathways (8 papers), Prostate Cancer Treatment and Research (7 papers), Autophagy in Disease and Therapy (7 papers), Cancer-related molecular mechanisms research (7 papers), RNA Research and Splicing (6 papers) and Hippo pathway signaling and YAP/TAZ (5 papers). The work is most often cited by research in Cancer Research (514 citations), Molecular Biology (1.4k citations), Cell Biology (270 citations), Oncology (343 citations) and Pulmonary and Respiratory Medicine (371 citations). Chenji Wang has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Long Yu, Pingzhao Zhang, Haojie Huang, Kun Gao, Jian An, Yibin Deng, Jiucun Wang, Yinghui Zhou, Jin Li and Minghua Wang. Their work appears in journals such as Cell Death and Differentiation, Cell Death and Disease, Cancer Letters, PLoS ONE and Autophagy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.